REGISTERED NUMBER: 03163077 (England and Wales)

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

PLEDGER PHARMACY LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Mr H R Garden

Mr C J S Ball

Mrs A P Garden

Mrs D Ball

Mr B F S Ball

Mr J M S Ball

Miss C A Garden

Miss L L Garden

Mrs E C S Lowe

Mr L M Garden

REGISTERED OFFICE:

The Anchorage

Chandler Road

Stoke Holy Cross

Norfolk

NR14 8RQ

REGISTERED NUMBER:

03163077 (England and Wales)

ACCOUNTANTS:

Sexty & Co

Chartered Certified Accountants

124 Thorpe Road

Norwich

Norfolk

NR1 1RS

FIXED ASSETS

Tangible assets

4

66,908

73,433

CURRENT ASSETS

Stocks

5

80,250

95,133

Debtors

6

112,296

130,327

Cash at bank and in hand

60,862

126,279

253,408

351,739

CREDITORS

Amounts falling due within one year

7

240,136

336,654

NET CURRENT ASSETS

13,272

15,085

TOTAL ASSETS LESS CURRENT LIABILITIES

80,180

88,518

PROVISIONS FOR LIABILITIES

2,700

3,300

NET ASSETS

77,480

85,218

CAPITAL AND RESERVES

Called up share capital

24

24

Retained earnings

77,456

85,194

SHAREHOLDERS' FUNDS

77,480

85,218

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 October 2025 and were signed on its behalf by:

Mr C J S Ball - Director

1.	STATUTORY INFORMATION

Pledger Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Land and buildings

-

4% on cost

Plant and machinery etc

-

15% on reducing balance

Stocks

Stock is valued by professional valuers at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2024 - 12 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

Short

and

leasehold

fittings

Totals

£

£

£

COST

At 1 April 2024

and 31 March 2025

88,500

45,083

133,583

DEPRECIATION

At 1 April 2024

32,339

27,386

59,725

Charge for year

3,540

3,410

6,950

At 31 March 2025

35,879

30,796

66,675

NET BOOK VALUE

At 31 March 2025

52,621

14,287

66,908

At 31 March 2024

56,161

17,697

73,858

5.

STOCKS

2025

2024

£

£

Stocks

80,250

95,133

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

90,201

106,767

Other debtors

22,095

23,560

112,296

130,327

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade creditors

125,945

189,647

Taxation and social security

12,728

14,241

Other creditors

101,463

132,766

240,136

336,654